More important, this kits report was barely readable: just a black-and-white spreadsheet of names, test results, and incompletely explained EPA standards
This is my second purchase and arrived to UK in 6 days
BPC-157 was placed in Category 2 ("may present significant safety risks") in 2023, removed from that category in April 2026, and is now set for a Pharmacy Compounding Advisory Committee review in late July 2026, while CJC-1295 and Ipamorelin were placed in Category 2 back in October 2023
It is the result of fixed biological differences in body composition, enzyme activity, and the mathematical constants used in alcohol pharmacokinetics
For a person taking the standard dose, a years supply would cost $6,000
You can subscribe from there